Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis

Journal of Virology
Laura FantuzziSandra Gessani

Abstract

Dendritic cells (DCs) play a crucial role in bridging innate and acquired immune responses to pathogens. In human immunodeficiency virus type 1 (HIV-1) infection, immature DCs (iDCs) are also main targets for HIV-1 at the mucosal level. In this study, we evaluated the effects of HIV-1-DC interactions on the maturation and functional activity of these cells. Exposure of human monocyte-derived iDCs to either aldrithiol-2-inactivated HIV-1 or gp120 led to an upmodulation of activation markers indicative of functional maturation. Despite their phenotype, these cells retained antigen uptake capacity and showed an impaired ability to secrete cytokines or chemokines and to induce T-cell proliferation. Although gp120 did not interfere with DC differentiation, the capacity of these cells to produce interleukin-12 (IL-12) upon maturation was markedly reduced. Likewise, iDCs stimulated by classical maturation factors in the presence of gp120 lacked allostimulatory capacity and did not produce IL-12, in spite of their phenotype typical of activated DCs. Exogenous addition of IL-12 restores the allostimulatory capacity of gp120-exposed DCs. The finding that gp120 induces abnormal maturation of DCs linked to profound suppression of their act...Continue Reading

References

Apr 1, 1994·The Journal of Experimental Medicine·J ChehimiG Trinchieri
Mar 1, 1993·Immunology Today·M Clerici, G M Shearer
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·J J SchnorrS Schneider-Schaulies
Jun 1, 1997·Immunology Today·S Romagnani
Sep 18, 1997·The Journal of Experimental Medicine·I Fugier-VivierC Rabourdin-Combe
Oct 30, 1999·European Journal of Immunology·M SalioA Lanzavecchia
Jun 3, 2000·Annual Review of Immunology·J BanchereauK Palucka
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L J HoJ H Lai
Mar 29, 2001·Nature Immunology·B Moser, P Loetscher
Mar 29, 2001·Trends in Immunology·A K Sewell, D A Price
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L FantuzziS Gessani
Jul 14, 2001·Science·B PulendranJ Banchereau
Aug 18, 2001·Cell·A Lanzavecchia, F Sallusto
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emanuele Fanales-BelasioBarbara Ensoli
Apr 24, 2002·Experimental Cell Research·Maria Giovanna QuarantaMarina Viora
Jun 29, 2002·Current Opinion in Immunology·Karolina Palucka, Jacques Banchereau
Aug 30, 2002·Trends in Immunology·Manfred B Lutz, Gerold Schuler
Sep 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria Cristina GauzziSandra Gessani
Sep 13, 2002·Immunology and Cell Biology·Karsten MahnkeHelmut Jonuleit
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Davorka MessmerMelissa Pope
Jan 16, 2003·Immunology Letters·Bernhard Moser, Lisa Ebert
Mar 5, 2003·Annual Review of Immunology·Ralph M SteinmanMichel C Nussenzweig
Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Siddhartha MahantyBali Pulendran
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tatsuyoshi KawamuraAndrew Blauvelt
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela DolganiucGyongyi Szabo

❮ Previous
Next ❯

Citations

Mar 9, 2006·Current HIV/AIDS Reports·Susanna Grundström, Jan Andersson
Mar 27, 2009·AIDS Research and Human Retroviruses·Rita CavaleiroAna E Sousa
Apr 19, 2011·AIDS Research and Human Retroviruses·Per Johan KlasseJohn P Moore
Feb 28, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Stephanie M DillonCara C Wilson
Jun 29, 2012·Clinical and Vaccine Immunology : CVI·Janakiraman VaniJagadeesh Bayry
Jun 24, 2010·Retrovirology·Trine H MogensenSøren R Paludan
Nov 7, 2007·PLoS Pathogens·Meimei ShanJohn P Moore
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Elena MartinelliAnthony S Fauci
Nov 25, 2006·The Lancet Infectious Diseases·Mahdad NoursadeghiRobert F Miller
Jul 28, 2005·International Journal of Experimental Pathology·Gabriele PollaraDavid R Katz
Mar 27, 2007·Cellular Microbiology·Claudette L FullerSina Bavari
Sep 5, 2012·Clinical and Experimental Immunology·P Fairman, J B Angel
Aug 3, 2013·Reviews in Medical Virology·Andrew N HarmanPaul U Cameron
Jun 19, 2013·Acta Tropica·Kerstin WahlersMartin P Grobusch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.